Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1981 1
1983 2
1984 1
1985 3
1986 2
1987 3
1988 3
1989 5
1990 7
1991 8
1992 5
1993 6
1994 14
1995 7
1996 12
1997 10
1998 12
1999 14
2000 18
2001 12
2002 16
2003 29
2004 35
2005 38
2006 39
2007 56
2008 82
2009 84
2010 82
2011 102
2012 114
2013 164
2014 173
2015 189
2016 231
2017 213
2018 295
2019 318
2020 399
2021 493
2022 570
2023 541
2024 265

Text availability

Article attribute

Article type

Publication date

Search Results

4,124 results

Results by year

Filters applied: . Clear all
Page 1
Tryptophan metabolism in health and disease.
Xue C, Li G, Zheng Q, Gu X, Shi Q, Su Y, Chu Q, Yuan X, Bao Z, Lu J, Li L. Xue C, et al. Cell Metab. 2023 Aug 8;35(8):1304-1326. doi: 10.1016/j.cmet.2023.06.004. Epub 2023 Jun 22. Cell Metab. 2023. PMID: 37352864 Review.
Tumor immunogenicity dictates reliance on TCF1 in CD8+ T cells for response to immunotherapy.
Escobar G, Tooley K, Oliveras JP, Huang L, Cheng H, Bookstaver ML, Edwards C, Froimchuk E, Xue C, Mangani D, Krishnan RK, Hazel N, Rutigliani C, Jewell CM, Biasco L, Anderson AC. Escobar G, et al. Among authors: xue c. Cancer Cell. 2023 Sep 11;41(9):1662-1679.e7. doi: 10.1016/j.ccell.2023.08.001. Epub 2023 Aug 24. Cancer Cell. 2023. PMID: 37625402
Ligand recognition and G protein coupling of the human itch receptor MRGPRX1.
Guo L, Zhang Y, Fang G, Tie L, Zhuang Y, Xue C, Liu Q, Zhang M, Zhu K, You C, Xu P, Yuan Q, Zhang C, Liu L, Rong N, Peng S, Liu Y, Wang C, Luo X, Lv Z, Kang D, Yu X, Zhang C, Jiang Y, Dong X, Zhou J, Liu Z, Yang F, Eric Xu H, Sun JP. Guo L, et al. Among authors: xue c. Nat Commun. 2023 Aug 17;14(1):5004. doi: 10.1038/s41467-023-40705-z. Nat Commun. 2023. PMID: 37591889 Free PMC article.
New antifungal strategies: Drug combination and co-delivery.
Zhu P, Li Y, Guo T, Liu S, Tancer RJ, Hu C, Zhao C, Xue C, Liao G. Zhu P, et al. Among authors: xue c. Adv Drug Deliv Rev. 2023 Jul;198:114874. doi: 10.1016/j.addr.2023.114874. Epub 2023 May 19. Adv Drug Deliv Rev. 2023. PMID: 37211279 Review.
Recent advances in CRISPR-Cas9-based genome insertion technologies.
Chen X, Du J, Yun S, Xue C, Yao Y, Rao S. Chen X, et al. Among authors: xue c. Mol Ther Nucleic Acids. 2024 Feb 5;35(1):102138. doi: 10.1016/j.omtn.2024.102138. eCollection 2024 Mar 12. Mol Ther Nucleic Acids. 2024. PMID: 38379727 Free PMC article. Review.
Neoadjuvant palbociclib plus either giredestrant or anastrozole in oestrogen receptor-positive, HER2-negative, early breast cancer (coopERA Breast Cancer): an open-label, randomised, controlled, phase 2 study.
Hurvitz SA, Bardia A, Quiroga V, Park YH, Blancas I, Alonso-Romero JL, Vasiliev A, Adamchuk H, Salgado M, Yardley DA, Berzoy O, Zamora-Auñón P, Chan D, Spera G, Xue C, Ferreira E, Badovinac Crnjevic T, Pérez-Moreno PD, López-Valverde V, Steinseifer J, Fernando TM, Moore HM, Fasching PA; coopERA Breast Cancer study group. Hurvitz SA, et al. Among authors: xue c. Lancet Oncol. 2023 Sep;24(9):1029-1041. doi: 10.1016/S1470-2045(23)00268-1. Lancet Oncol. 2023. PMID: 37657462 Free article. Clinical Trial.
4,124 results